[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100554738":3},{"organization":4,"outcomesModule":7,"designInfo":31,"detailedDescription":30,"studyPopulation":30,"armGroups":38,"interventions":45,"overallOfficials":30,"centralContacts":50,"locations":56,"responsibleParty":207,"collaborators":30,"id":209,"slug":30,"hasResults":210,"nctId":211,"briefTitle":212,"officialTitle":213,"acronym":30,"eligibilityCriteria":214,"healthyVolunteers":210,"sex":215,"minAge":30,"maxAge":216,"enrollmentInfo":217,"targetDuration":30,"studyType":220,"phases":221,"briefSummary":223,"conditions":224,"keywords":226,"overallStatus":59,"whyStopped":30,"lastUpdateSubmitDate":227,"lastUpdatePostDateStruct":228,"startDateStruct":231,"completionDateStruct":233,"leadSponsor":235,"locationsCount":236},{"fullName":5,"class":6},"Amryt Pharma","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":15,"otherOutcomes":30},[9,13],{"measure":10,"description":11,"timeFrame":12},"Percent change from baseline in fasting serum TG levels at Month 12 for subjects with fasting TG levels ≥2.3 mmol\u002FL (200 mg\u002FdL) at baseline","To evaluate the effectiveness of metreleptin in patients under 6 years of age with GL and associated diabetes mellitus and\u002For hypertriglyceridaemia","12 months",{"measure":14,"description":11,"timeFrame":12},"Absolute change from baseline in glycated haemoglobin (HbA1c) at Month 12 for subjects with HbA1c ≥6.5% at baseline",[16,19,21,23,25,27],{"measure":17,"description":18,"timeFrame":12},"Proportion of subjects of those with Baseline HbA1c ≥6.5% achieving target actual decreases of at least 0.5%, 1%, 1.5%, 2% absolute decrease in HbA1c or HbA1c \u003C6.5% or HbA1c \u003C5.7% at Month 12","To evaluate the efficacy of metreleptin treatment in patients with GL",{"measure":20,"description":18,"timeFrame":12},"Proportion of subjects of those with Baseline HbA1c ≥5.7% achieving target actual decreases of at least 0.5%, 1%, 1.5%, 2% absolute decrease in HbA1c or HbA1c \u003C5.7% at Month 12",{"measure":22,"description":18,"timeFrame":12},"Proportion of subjects of those with fasting serum TG ≥ 1.7 mmol\u002FL (150 mg\u002FdL) achieving target actual decreases from baseline of at least 15%, 20%, 25%, 30%, 35%, 40% at Month 12",{"measure":24,"description":18,"timeFrame":12},"Proportion of subjects of those with fasting serum TG ≥ 2.3 mmol\u002FL (200 mg\u002FdL) achieving target actual decreases from baseline of at least 15%, 20%, 25%, 30%, 35%, 40% at Month 12",{"measure":26,"description":18,"timeFrame":12},"Change from baseline in liver volume and liver span as assessed by ultrasound at each post-baseline visit through Month 12",{"measure":28,"description":29,"timeFrame":12},"Incidence of, treatment emergent adverse events (TEAEs), serious adverse events (SAEs), treatment related adverse events (AEs), AEs of special interest (AESIs) and AEs leading to study drug discontinuation","To assess safety and tolerability of metreleptin",null,{"allocation":32,"interventionModel":33,"interventionModelDescription":34,"primaryPurpose":35,"observationalModel":30,"timePerspective":30,"maskingInfo":36},"NA","SINGLE_GROUP","Single Group Assignment","TREATMENT",{"masking":37,"maskingDescription":30,"whoMasked":30},"NONE",[39],{"label":40,"type":41,"description":42,"interventionNames":43},"Metreleptin","EXPERIMENTAL","Metreleptin \\[Recombinant-methionyl human Leptin; rmetHuLeptin\\] for daily injection is a sterile, white, solid lyophilised cake",[44],"Drug: Metreleptin",[46],{"type":47,"name":40,"description":48,"armGroupLabels":49,"otherNames":30},"DRUG","Metreleptin is a recombinant human leptin analog that is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency",[40],[51],{"name":52,"role":53,"phone":54,"phoneExt":30,"email":55},"Janet Boylan","CONTACT","+3905212791","clinicaltrials_info@chiesi.com",[57,73,87,95,110,122,136,148,160,172,184,195],{"facility":58,"status":59,"city":60,"state":30,"zip":61,"country":62,"countryCode":63,"cosmosGeoPoint":64,"geoPoint":69,"contacts":70},"UZ Leuven","RECRUITING","Leuven","3000","Belgium","BE",{"type":65,"coordinates":66},"Point",[67,68],4.70093,50.87959,{"lat":68,"lon":67},[71],{"name":72,"role":53,"phone":30,"phoneExt":30,"email":30},"Kristina Casteels",{"facility":74,"status":59,"city":75,"state":30,"zip":76,"country":77,"countryCode":78,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Hôpital Necker - Enfants Malades","Paris","75015","France","FR",{"type":65,"coordinates":80},[81,82],2.3488,48.85341,{"lat":82,"lon":81},[85],{"name":86,"role":53,"phone":30,"phoneExt":30,"email":30},"Jacques Beltrand",{"facility":88,"status":59,"city":75,"state":30,"zip":30,"country":77,"countryCode":78,"cosmosGeoPoint":89,"geoPoint":91,"contacts":92},"Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Universitaire Robert-Debre",{"type":65,"coordinates":90},[81,82],{"lat":82,"lon":81},[93],{"name":94,"role":53,"phone":30,"phoneExt":30,"email":30},"Elise Bismuth",{"facility":96,"status":97,"city":98,"state":30,"zip":99,"country":100,"countryCode":101,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Universitätsklinikum Hamburg-Eppendorf","NOT_YET_RECRUITING","Hamburg","20251","Germany","DE",{"type":65,"coordinates":103},[104,105],9.99302,53.55073,{"lat":105,"lon":104},[108],{"name":109,"role":53,"phone":30,"phoneExt":30,"email":30},"Konstantinos Tsiakas",{"facility":111,"status":59,"city":112,"state":30,"zip":113,"country":100,"countryCode":101,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Universitaetsklinikum Ulm - Klinik fuer Kinder- und Jugendmedizin","Ulm","89075",{"type":65,"coordinates":115},[116,117],9.99155,48.39841,{"lat":117,"lon":116},[120],{"name":121,"role":53,"phone":30,"phoneExt":30,"email":30},"Martin Wabitsch",{"facility":123,"status":59,"city":124,"state":30,"zip":125,"country":126,"countryCode":127,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"IRCCS Ospedale Pediatrico Bambino Gesù","Chieti","66100","Italy","IT",{"type":65,"coordinates":129},[130,131],14.16494,42.34827,{"lat":131,"lon":130},[134],{"name":135,"role":53,"phone":30,"phoneExt":30,"email":30},"Stefano Tumini",{"facility":137,"status":59,"city":138,"state":30,"zip":139,"country":126,"countryCode":127,"cosmosGeoPoint":140,"geoPoint":144,"contacts":145},"Azienda Ospedaliera Universitaria \"Federico II\"","Naples","80131",{"type":65,"coordinates":141},[142,143],14.26811,40.85216,{"lat":143,"lon":142},[146],{"name":147,"role":53,"phone":30,"phoneExt":30,"email":30},"Enza Mozzillo",{"facility":149,"status":59,"city":150,"state":30,"zip":151,"country":126,"countryCode":127,"cosmosGeoPoint":152,"geoPoint":156,"contacts":157},"Azienda Ospedaliero Universitaria Maggiore della Carità di Novara","Novara","28100",{"type":65,"coordinates":153},[154,155],8.62118,45.44694,{"lat":155,"lon":154},[158],{"name":159,"role":53,"phone":30,"phoneExt":30,"email":30},"Flavia Prodam",{"facility":161,"status":59,"city":162,"state":30,"zip":163,"country":126,"countryCode":127,"cosmosGeoPoint":164,"geoPoint":168,"contacts":169},"Azienda Ospedaliero-Universitaria di Parma","Parma","43126",{"type":65,"coordinates":165},[166,167],10.32618,44.79935,{"lat":167,"lon":166},[170],{"name":171,"role":53,"phone":30,"phoneExt":30,"email":30},"Maria Street",{"facility":173,"status":59,"city":174,"state":30,"zip":175,"country":126,"countryCode":127,"cosmosGeoPoint":176,"geoPoint":180,"contacts":181},"Azienda Ospedaliero Universitaria Pisana","Pisa","56124",{"type":65,"coordinates":177},[178,179],10.4036,43.70853,{"lat":179,"lon":178},[182],{"name":183,"role":53,"phone":30,"phoneExt":30,"email":30},"Giovanni Ceccarini",{"facility":123,"status":59,"city":185,"state":30,"zip":186,"country":126,"countryCode":127,"cosmosGeoPoint":187,"geoPoint":191,"contacts":192},"Rome","00165",{"type":65,"coordinates":188},[189,190],12.51133,41.89193,{"lat":190,"lon":189},[193],{"name":194,"role":53,"phone":30,"phoneExt":30,"email":30},"Marco Cappa",{"facility":196,"status":59,"city":197,"state":30,"zip":198,"country":126,"countryCode":127,"cosmosGeoPoint":199,"geoPoint":203,"contacts":204},"Ospedale Filippo Del Ponte Varese - ASST Sette Laghi","Varese","21100",{"type":65,"coordinates":200},[201,202],8.82511,45.82058,{"lat":202,"lon":201},[205],{"name":206,"role":53,"phone":30,"phoneExt":30,"email":30},"Gianluca Musolino",{"type":208,"investigatorFullName":30,"investigatorTitle":30,"investigatorAffiliation":30,"oldNameTitle":30,"oldOrganization":30},"SPONSOR","100554738",false,"NCT06502990","Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy","Open-label, Phase 3b Study to Evaluate Effectiveness, Safety and Pharmacokinetic Parameters of Metreleptin in Patients Under 6 Years of Age With Generalised Lipodystrophy and Associated Diabetes Mellitus and\u002For Hypertriglyceridaemia","Inclusion Criteria:\n\n* Confirmed diagnosis of Generalised Lipodystrophy\n* Metreleptin treatment naive\n\nExclusion Criteria:\n\n* Weight \\\u003C9 kg at Screening (Visit 1)","ALL","5 Years",{"count":218,"type":219},15,"ESTIMATED","INTERVENTIONAL",[222],"PHASE3","This is an open-label, Phase 3b study to evaluate effectiveness, safety and pharmacokinetic parameters of metreleptin in patients under 6 years of age with generalised lipodystrophy and associated diabetes mellitus and\u002For hypertriglyceridaemia",[225],"Generalized Lipodystrophy",[40],"2026-01-16",{"date":229,"type":230},"2026-01-20","ACTUAL",{"date":232,"type":230},"2025-05-23",{"date":234,"type":219},"2026-09-30",{"name":5,"class":6},12]